home / stock / repl / repl short
Short Information | Replimune Group Inc. (NASDAQ:REPL)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 6,452,074 |
Total Actual Volume | 42,982,326 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 322,604 |
Average Short Percentage | 16.98% |
Is there a REPL Short Squeeze or Breakout about to happen?
See the REPL Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-03-2024 | $8.5 | $8.09 | $8.5 | $7.95 | 519,616 | 117,547 | 22.62% |
07-02-2024 | $9.3 | $8.37 | $9.37 | $8.18 | 921,916 | 155,177 | 16.83% |
07-01-2024 | $8.98 | $9.36 | $9.49 | $8.83 | 1,161,299 | 115,684 | 9.96% |
06-28-2024 | $8.55 | $9 | $9 | $8.3 | 1,784,172 | 170,709 | 9.57% |
06-27-2024 | $8.7 | $8.52 | $8.79 | $8.33 | 523,254 | 51,569 | 9.86% |
06-26-2024 | $8.78 | $8.71 | $8.82 | $8.42 | 875,431 | 212,091 | 24.23% |
06-25-2024 | $8.71 | $8.82 | $9.005 | $8.54 | 846,830 | 211,924 | 25.03% |
06-24-2024 | $8.47 | $8.76 | $9.11 | $8.47 | 1,059,108 | 178,116 | 16.82% |
06-21-2024 | $7.9 | $8.5 | $8.86 | $7.86 | 9,777,100 | 364,340 | 3.73% |
06-20-2024 | $7.69 | $7.87 | $7.94 | $7.31 | 1,444,899 | 307,466 | 21.28% |
06-18-2024 | $7.8 | $7.64 | $7.91 | $7.45 | 1,411,556 | 166,054 | 11.76% |
06-17-2024 | $8.27 | $7.81 | $8.27 | $7.31 | 3,033,726 | 561,655 | 18.51% |
06-14-2024 | $9.43 | $8.365 | $9.5495 | $8.315 | 1,583,489 | 310,100 | 19.58% |
06-13-2024 | $9.22 | $9.46 | $9.755 | $9.08 | 2,000,971 | 349,185 | 17.45% |
06-12-2024 | $9.15 | $8.82 | $9.57 | $8.59 | 1,187,984 | 166,738 | 14.04% |
06-11-2024 | $8.64 | $9 | $9.27 | $8.46 | 1,822,554 | 307,848 | 16.89% |
06-10-2024 | $7.765 | $9 | $9.4 | $7.66 | 3,612,013 | 732,686 | 20.28% |
06-07-2024 | $7.26 | $7.9 | $8.04 | $6.696 | 2,622,480 | 531,882 | 20.28% |
06-06-2024 | $5.75 | $7.11 | $7.27 | $5.66 | 5,842,671 | 1,257,867 | 21.53% |
06-05-2024 | $5.1 | $5.56 | $5.6 | $4.93 | 951,257 | 183,436 | 19.28% |
News, Short Squeeze, Breakout and More Instantly...
- Led by a life-sciences focused institutional investor, with participation from Redmile Group, RTW Investments, Boxer Capital and other institutional investors - - Financing follows strong primary analysis data from the RP1 IGNYTE clinical trial in anti-PD1 failed melanoma; BLA fi...
WOBURN, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced that Sushil Patel, Chief Executive Officer of Replimune, will present at the Gold...
2024-06-07 07:00:05 ET Robert Burns from H.C. Wainwright issued a price target of $17.00 for REPL on 2024-06-07 06:07:00. The adjusted price target was set to $17.00. At the time of the announcement, REPL was trading at $7.11. The overall price target consensus is at $26...